These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26522905)

  • 1. Neuropharmacology of Poststroke Motor and Speech Recovery.
    Keser Z; Francisco GE
    Phys Med Rehabil Clin N Am; 2015 Nov; 26(4):671-89. PubMed ID: 26522905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy in restorative neurology.
    Liepert J
    Curr Opin Neurol; 2008 Dec; 21(6):639-43. PubMed ID: 18989105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy and motor recovery after stroke.
    Viale L; Catoira NP; Di Girolamo G; González CD
    Expert Rev Neurother; 2018 Jan; 18(1):65-82. PubMed ID: 29124985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of motor recovery after stroke: advances in biomarkers.
    Stinear CM
    Lancet Neurol; 2017 Oct; 16(10):826-836. PubMed ID: 28920888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study.
    Restemeyer C; Weiller C; Liepert J
    Restor Neurol Neurosci; 2007; 25(2):143-50. PubMed ID: 17726273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Road to recovery: drugs used in stroke rehabilitation.
    Zorowitz RD
    Expert Rev Neurother; 2004 Mar; 4(2):219-31. PubMed ID: 15853563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on pharmacotherapy for stroke and traumatic brain injury recovery during rehabilitation.
    Liepert J
    Curr Opin Neurol; 2016 Dec; 29(6):700-705. PubMed ID: 27748687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier?
    Gladstone DJ; Black SE
    Can J Neurol Sci; 2000 May; 27(2):97-105. PubMed ID: 10830340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review.
    Berends HI; Nijlant JM; Movig KL; Van Putten MJ; Jannink MJ; Ijzerman MJ
    Eur J Phys Rehabil Med; 2009 Dec; 45(4):621-30. PubMed ID: 20032921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bringing proportional recovery into proportion: Bayesian modelling of post-stroke motor impairment.
    Bonkhoff AK; Hope T; Bzdok D; Guggisberg AG; Hawe RL; Dukelow SP; Rehme AK; Fink GR; Grefkes C; Bowman H
    Brain; 2020 Jul; 143(7):2189-2206. PubMed ID: 32601678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine and other pharmacological agents in human and animal studies of recovery from stroke.
    Walker-Batson D; Mehta J; Smith P; Johnson M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():225-30. PubMed ID: 25896190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor Outcome of Stroke Patients with Low Dose Levodopa Therapy.
    Das UK; Uddin MJ; Bhattacharjee M; Sarker UK; Talukder RK; Saha G; Rahman MA; Kamal MZ; Banu NR; Shill SK
    Mymensingh Med J; 2019 Oct; 28(4):762-766. PubMed ID: 31599238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and determinants of using pharmacological enhancement in the clinical practice of in-hospital stroke rehabilitation.
    Engelter ST; Urscheler N; Baronti F; Vuadens P; Koch J; Frank M; Disserens K; Jenni W
    Eur Neurol; 2012; 68(1):28-33. PubMed ID: 22677938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic effects on encoding of a motor memory in chronic stroke.
    Floel A; Hummel F; Breitenstein C; Knecht S; Cohen LG
    Neurology; 2005 Aug; 65(3):472-4. PubMed ID: 16087920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of cellex on cognitive and speech impairments in the acute stage of stroke].
    Kovalenko AV; Safronova MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):40-44. PubMed ID: 25909788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine and post-stroke rehabilitation: indications and controversies.
    Walker-Batson D
    Eur J Phys Rehabil Med; 2013 Apr; 49(2):251-60. PubMed ID: 23558704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological enhancement of motor recovery in subacute and chronic stroke.
    Rösser N; Flöel A
    NeuroRehabilitation; 2008; 23(1):95-103. PubMed ID: 18356593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333).
    Sprigg N; Willmot MR; Gray LJ; Sunderland A; Pomeroy V; Walker M; Bath PM
    J Hum Hypertens; 2007 Aug; 21(8):616-24. PubMed ID: 17443208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of piracetam in the treatment of acute and chronic aphasia.
    Huber W
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():38-43. PubMed ID: 10338107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prestroke/poststroke fMRI in aphasia: perilesional hemodynamic activation and language recovery.
    Lidzba K; Staudt M; Zieske F; Schwilling E; Ackermann H
    Neurology; 2012 Jan; 78(4):289-91. PubMed ID: 22238411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.